A dataset linking 45,988 finished phase 2–3 drug trials on ClinicalTrials.gov (2010–2026) to subsequent FDA approval of the drugs tested

An article created on 2026-10-22 06:43:16

#	Наименование новости	Информативность	Дата публикации
1	Enrollment cuts and primary-outcome changes, not completion-date delays, predict the termination of industry phase 2–3 drug trials: a landmark analysis of ClinicalTrials.gov version histories	19.01	22-10-2026
2	Patient Preferences for Biologic Therapies in Chronic Disease: A Systematic Review of Discrete Choice Experiments	14.76	10-08-2026
3	Effects of Perioperative Cross-Sectional Pharmacological Management on Medical Safety: A 10-Year Retrospective Observational Study	18.53	07-08-2026
4	Platinum-Based Chemotherapies-Induced Nephrotoxicity: A Retrospective Analysis of Frequency, Clinical Characteristics, and Outcomes	26.67	10-08-2026
5	Building a clinical and academic health research network using data science and artificial intelligence	13.78	20-08-2026
6	Disparities in Drug Access between Japan and the United States for Designated Intractable Diseases: A Cross-Sectional Analysis of Approval Status, Prevalence, and Drug Lag	14.93	19-08-2026
7	Clinical Tasks Explain AI Readiness Across Medical Specialties	17.14	22-10-2026
8	Medication adherence in patients with cognitive disorders	17.69	20-08-2026
9	Battery-Aware Finsler Geometry for Energy-Optimal Routing of Electric Vehicles	30	22-10-2026
10	Boletín sobre Seguridad de Medicamentos de Uso Humano. Mayo de 2026	6.35	22-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 16.64. Источник: www.researchsquare.com.

Найдите то, что Вас интересует